Ascendis Pharma AS

Ascendis Pharma A/S is a biopharmaceutical company focused on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. Its products include SKYTROFA for pediatric patients with growth hormone deficiency and YORVIPATH, a once-daily subcutaneous injection for adults with chronic hypoparathyroidism. The company is also developing three independent endocrinology rare disease product candidates in clinical development and advancing oncology therapeutic candidates. Incorporated in 2006, Ascendis Pharma is based in Hellerup, Denmark.